永久支持性住房中的无烟家庭干预:一项整群随机临床试验
该整群随机临床试验纳入旧金山湾区40个多单元永久支持性住房(PSH)站点的400名居民(干预组191人,对照组209人),评估由研究人员提供的一对一面对面简短无烟家庭干预(对照组为等待名单)的效果。主要终点为6个月时持续≥90天无烟家庭采纳率和7天一氧化碳验证的时点戒烟率(PPA,呼出气CO≤5 ppm)。结果显示,持续≥90天无烟家庭采纳率两组差异无统计学意义(6.8% vs 4.8%;OR 1.45,95%CI 0.69-3.07),但干预组7天PPA更高(6.3% vs 1.0%;OR 6.94,95%CI 1.69-28.45),且至少1天无烟家庭尝试率更高(63.4% vs 36.8%;调整OR 3.83,95%CI 2.63-5.57)。结论提示该简短干预可扩展但不足以维持长期效果,可能需要更强化的干预。
要点
- 在PSH居民中,简短无烟家庭干预未显著提高6个月时持续≥90天无烟家庭采纳率(6.8% vs 4.8%;OR 1.45,95%CI 0.69-3.07)。
- 干预组6个月时7天CO验证PPA(≤5 ppm)高于对照组(6.3% vs 1.0%;OR 6.94,95%CI 1.69-28.45)。
- 干预组至少1天无烟家庭尝试率显著高于对照组(63.4% vs 36.8%;调整OR 3.83,95%CI 2.63-5.57)。
- 工作人员在6个月时提供戒烟治疗的信念和实践S-KAP评分较基线有所提高(信念+0.21分,实践+0.24分)。
- 结论提示该简短干预可扩展,但需更强化干预以维持长期无烟家庭采纳效果。
适用人群与场景
- 美国旧金山湾区40个多单元永久支持性住房(PSH)站点中,年龄≥18岁、在家中吸烟的居民;以及研究站点的工作人员。
- 排除标准原文未提及。
诊断标准与关键阈值
- 主要结局:持续≥90天无烟家庭采纳;7天一氧化碳验证的时点戒烟率(PPA),定义为呼出气一氧化碳水平≤5 ppm。
- 次要结局:过去90天内至少1天无烟家庭采纳;工作人员吸烟知识、态度和实践(S-KAP)评分变化。
处置流程与药物剂量
- 干预组居民接受由研究人员提供的一对一面对面无烟家庭采纳辅导。
- 对照组居民在研究期间不接受干预,但在干预组完成随访后获得干预。
- 两组站点工作人员均接受提供简短戒烟辅导的培训。
- 药物剂量、给药途径、频次或疗程原文未提及。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 整群随机临床试验,纳入40个PSH站点、400名居民(干预组191人,对照组209人;平均年龄54.5岁,男性63.1%)。
- 主要终点:6个月时持续≥90天无烟家庭采纳率干预组6.8%(13人) vs 对照组4.8%(10人),OR 1.45(95%CI 0.69-3.07)。
- 7天CO验证PPA(≤5 ppm):干预组6.3%(12人) vs 对照组1.0%(2人),OR 6.94(95%CI 1.69-28.45)。
- 至少1天无烟家庭采纳率:干预组63.4%(121人) vs 对照组36.8%(77人),调整OR 3.83(95%CI 2.63-5.57)。
- 工作人员S-KAP评分6个月较基线变化:信念+0.21(SD 0.55)分,实践+0.24(SD 0.61)分。
证据类型、等级与局限
- 研究类型:整群随机临床试验(cluster randomized clinical trial)。
- 证据等级或推荐强度原文未提及。
- 局限:原文未明确列出局限;设计上为整群随机、样本量400、随访6个月,干预为简短辅导。
对床旁实践的改变
- 对于PSH居民,简短一对一面对面无烟家庭辅导可增加至少1天的无烟家庭尝试率,但不足以显著提高持续≥90天的采纳率。
- 该干预可能提高短期CO验证戒烟率,但绝对人数少(干预组12人 vs 对照组2人),需结合临床判断。
- 若目标是长期无烟家庭采纳,可能需要更强化或持续干预;原文结论支持该方法的可扩展性但需更多干预维持效果。
- 对工作人员进行简短戒烟辅导培训可能改善其提供戒烟治疗的信念和实践评分。
指南或共识出处
- 原文未提及指南或共识名称;试验注册号:ClinicalTrials.gov Identifier: NCT04855357。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Chronic diseases related to tobacco use and secondhand smoke exposure are the leading causes of death among formerly homeless adults living in permanent supportive housing (PSH) in the US.
OBJECTIVE: To evaluate the efficacy of a brief, smoke-free home intervention in promoting voluntary smoke-free home adoption among PSH residents.
DESIGN, SETTING, AND PARTICIPANTS: In this cluster randomized clinical trial, data collection occurred from January 11, 2022, to March 31, 2025. Participants were residents aged 18 years or older who smoked cigarettes at home in 40 multiunit PSH sites in the San Francisco Bay area, randomized to intervention or waiting list control clusters, and housing staff who worked at the study sites.
INTERVENTION: Residents in intervention sites received one-on-one in-person coaching from research staff on adopting a smoke-free home; waiting list control site residents received no interventions during the study but were offered the intervention once the intervention group completed follow-up. Staff in both intervention and control sites received training on providing brief tobacco cessation coaching.
MAIN OUTCOMES AND MEASURES: Primary outcomes were smoke-free home adoption for at least 90 days and 7-day carbon monoxide-verified point prevalence abstinence (PPA; expired carbon monoxide level ≤5 ppm) at 6 months. Secondary outcomes were any adoption (≥1 day) of a smoke-free home in the past 90 days among residents and changes in Smoking Knowledge, Attitudes, and Practices (S-KAP) scores among staff.
RESULTS: The trial enrolled 400 residents (mean [SD] age, 54.5 [10.7] years; 251 [63.1%] male), 191 in the intervention and 209 in the control cluster. At 6 months, 13 residents (6.8%) in the intervention and 10 (4.8%) in the control group adopted a smoke-free home for at least 90 days (odds ratio [OR], 1.45; 95% CI, 0.69-3.07). Few residents achieved 7-day PPA, though more intervention residents (12 [6.3%]) achieved it compared with controls (2 [1.0%]) (OR, 6.94; 95% CI, 1.69-28.45). Intervention residents had greater odds than control residents of any smoke-free home adoption of at least 1 day (121 [63.4%] vs 77 [36.8%]; adjusted OR, 3.83 [95% CI, 2.63-5.57]). Among staff, mean (SD) S-KAP scores increased at 6 months vs baseline for beliefs (by 0.21 [0.55] points) and practices (by 0.24 [0.61] points) pertaining to providing cessation treatment.
CONCLUSIONS AND RELEVANCE: In this cluster randomized clinical trial, the brief intervention did not result in a significant increase in smoke-free home adoption for at least 90 days, though more residents in the intervention than the control group attempted adoption for at least 1 day. These findings support the scalability of this approach to reduce smoking in PSH, but more intensive interventions may be needed to sustain intervention effects.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04855357.
参考来源
- Hawes MR, Alway J, Chakravarty D, et al. Smoke-Free Home Intervention in Permanent Supportive Housing: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2026. PMID: 42714909. doi:10.1001/jamanetworkopen.2026.32697
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。